Health

Optum has signed on to the fight against obesity, backing the telemedicine programme provider and taking its overall funding to over $127m.

M12 helped cybersecurity software producer Hunters raise $30m while Scor and Transamerica are set to exit patient monitoring software developer 100Plus.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Bristol Myers Squibb returned to reinvest in the cardiac disease therapy developer having backed its 2017 series A round with Boehringer Ingelheim.

Utah spinout Techcyte has received $21m in funding, three and a half years after its series A round.

Hannover Medical School spinout Cardior has welcomed both new and existing backers, such as Bristol Myers Squibb, for a series B round led by Inkef Capital.

Exploiting research at University of Pittsburgh and UPMC, Novasenta has been established with $20m in seed financing.

The series C1 round pushed the Sanofi and Alexandria Real Estate Equities-backed oral therapeutics developer’s total funding to about $200m.

Immunotherapy developer Elixiron has closed its series A1 round with capital from investors including Hong Tai Electric Industrial.

Osage University Partners is among the returning backers that have helped push Stanford-linked Dice Molecules’ total funding to around $200m.

TXOne Nertworks has added $12.9m to its coffers, while C3 has pushed its series B round to $90m thanks to a $10m extension.